There are 2949 resources available
1360P - Identification of epidermal growth factor receptor (EGFR) fusions in a large Chinese lung cancer population
Presenter: Dongyuan Zhu
Session: E-Poster Display
Resources:
Abstract
1361P - Determination of ALK rearrangements in non-small cell lung cancer: Clinical and economic impact of current practice in Spain
Presenter: Luis Cabezón Gutiérrez
Session: E-Poster Display
Resources:
Abstract
1362P - Clinical and real-world outcomes in patients with epidermal growth factor receptor (EGFR) exon 20 insertions in non-small cell lung cancer (NSCLC): A meta-analysis
Presenter: Dimitrios Tomaras
Session: E-Poster Display
Resources:
Abstract
1363P - Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL)
Presenter: Kristof Cuppens
Session: E-Poster Display
Resources:
Abstract
1364P - Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
Presenter: Frank Griesinger
Session: E-Poster Display
Resources:
Abstract
1365P - A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)
Presenter: Rintaro Noro
Session: E-Poster Display
Resources:
Abstract
1366P - Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance (date updated)
Presenter: Ruifen Tian
Session: E-Poster Display
Resources:
Abstract
1367P - Treatment duration and adherence in ALK+ non-small cell lung cancer patients treated with brigatinib following prior ALK TKI therapy in the US
Presenter: Huamao Lin
Session: E-Poster Display
Resources:
Abstract
1368P - Lorlatinib in pretreated ALK/ROS1-positive non-small cell lung cancer (NSCLC): Results from the German early access program
Presenter: Nikolaj Frost
Session: E-Poster Display
Resources:
Abstract
1369P - EGFR T790M ctDNA abundance and TP53 co-mutation by next generation sequencing predicted clinical outcomes of osimertinib in non-small cell lung cancer patients from a real-world study
Presenter: Tao Tian
Session: E-Poster Display
Resources:
Abstract